Seeing Is Believing
KRYS is currently covered by 8 analysts with an average price target of $198.17. This is a potential upside of $33.34 (20.23%) from yesterday's end of day stock price of $164.83.
Krystal Biotech's activity chart (see below) currently has 54 price targets and 66 ratings on display. The stock rating distribution of KRYS is 97.3% BUY and 2.7% HOLD.
Analysts average stock forecasts to be materialized ratio is 93.43% with an average time for these price targets to be met of 298.36 days.
Highest price target for KRYS is $221, Lowest price target is $175, average price target is $198.17.
Most recent stock forecast was given by GEULAH LIVSHITS from CHARDAN CAPITAL on 18-Dec-2024. First documented stock forecast 28-Jun-2018.
Currently out of the existing stock ratings of KRYS, 36 are a BUY (97.3%), 1 are a HOLD (2.7%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$212
$47.17 (28.62%)
$212
3 days ago
(18-Dec-2024)
7/9 (77.78%)
$43.47 (25.79%)
409
Buy
$221
$56.17 (34.08%)
$221
3 days ago
(18-Dec-2024)
25/30 (83.33%)
$52.47 (31.13%)
199
Buy
$220
$55.17 (33.47%)
$145
3 months 10 days ago
(11-Sep-2024)
2/3 (66.67%)
$21.21 (10.67%)
157
Buy
$180
3 months 22 days ago
(29-Aug-2024)
4/4 (100%)
$65.38 (57.04%)
139
Buy
$175
$10.17 (6.17%)
$130
9 months 24 days ago
(27-Feb-2024)
4/4 (100%)
$4.85 (2.85%)
135
What is KRYS (Krystal Biotech) average time for price targets to be met?
Which analyst has the current highest performing score on KRYS (Krystal Biotech) with a proven track record?
Which analyst has the most public recommendations on KRYS (Krystal Biotech)?
Which analyst is the currently most bullish on KRYS (Krystal Biotech)?
Which analyst is the currently most reserved on KRYS (Krystal Biotech)?